Rare, but widespread: a disease is considered rare when fewer than five out of 10,000 people are affected. However, more than 300 million people worldwide live with a rare disease. ref1 Complex clinical pictures make diagnosis difficult. Ada’s prototype for a clinical decision-support tool can support timely rare disease detection.
“We cannot accept the fact that people living with a rare disease often wait six years for the correct diagnosis. Artificial intelligence gives us the opportunity to change this and make a fundamental difference to the lives of millions of people worldwide.”
Co-founder & Chief Scientific Officer
Ada’s pioneering artificial intelligence works for patients and doctors to achieve better rare disease health outcomes:
Thousands of conditions and symptoms
8 years’ research and technology development
Trained with thousands of real cases
Empower patients and raise awareness
Ada helps millions globally assess symptoms of rare and common diseases and shares patient-friendly information to help people understand their condition and how to manage it.
Reduce detection timeframes
Timely, accurate diagnoses help prevent unnecessary tests, improve referral efficiency, and initiate correct treatment.
Support collaboration and clinical research
Collecting evidence into one transparent system enables specialists to review Ada’s suggestions and share anonymized cases for peer collaboration.
Nguengang Wakap, S., Lambert, D.M., Olry, A. et al. “Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database”. European Journal of Human Genetics 28, 165–173 (2020).
Rare Disease UK. “What is a rare disease?”